LD-2 disclosure · 3rd Quarter - Report
BRIDGEBIO PHARMA, INC.
via BRIDGEBIO PHARMA, INC.
Expenses$170Kself-filed spend
Client
- Name
- BRIDGEBIO PHARMA, INC.
- Description
- Biotech company
- Location
- California · United States of America
Registrant
- Firm
- BRIDGEBIO PHARMA, INC.
- Location
- Palo Alto, California, United States of America
Lobbying activities
1 issuePharmacy
Creating Hope Reauthorization Act of 2024 - H.R. 7384 Give Kids a Chance Act of 2024 - H.R. 3433 Creating Hope Reauthorization Act of 2024 - S. 4583 March-in/Bayh-Dole Act Orphan drug policies
LobbyistsAMANDA MALAKOFF
TargetedSENATE · HOUSE OF REPRESENTATIVES